Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer

por Valdés-Mora, Fatima, Locke, Warwick J., Bandrés, Eva, Gallego-Ortega, David, Cejas, Paloma, García-Cabezas, Miguel Angel, Colino-Sanguino, Yolanda, Feliú, Jaime, del Pulgar, Teresa Gómez, Lacal, Juan Carlos
Publicado 2017

A Read/Write Mechanism Connects p300 Bromodomain Function to H2A.Z Acetylation

por Colino-Sanguino, Yolanda, Cornett, Evan M., Moulder, David, Smith, Grady C., Hrit, Joel, Cordeiro-Spinetti, Eric, Vaughan, Robert M., Krajewski, Krzysztof, Rothbart, Scott B., Clark, Susan J., Valdés-Mora, Fátima
Publicado 2019

Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson’s disease

por Tamburrino, Anna, Churchill, Madeline J., Wan, Oi W., Colino-Sanguino, Yolanda, Ippolito, Rossana, Bergstrand, Sofie, Wolf, Daniel A., Herz, Niculin J., Sconce, Michelle D., Björklund, Anders, Meshul, Charles K., Decressac, Mickael
Publicado 2015

Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer

por Valdés-Mora, Fátima, Gould, Cathryn M., Colino-Sanguino, Yolanda, Qu, Wenjia, Song, Jenny Z., Taylor, Kylie M., Buske, Fabian A., Statham, Aaron L., Nair, Shalima S., Armstrong, Nicola J., Kench, James G., Lee, Kenneth M. L., Horvath, Lisa G., Qiu, Minru, Ilinykh, Alexei, Yeo-Teh, Nicole S., Gallego-Ortega, David, Stirzaker, Clare, Clark, Susan J.
Publicado 2017

ALTEN: A High‐Fidelity Primary Tissue‐Engineering Platform to Assess Cellular Responses Ex Vivo

por Law, Andrew M. K., Chen, Jiamin, Colino‐Sanguino, Yolanda, de la Fuente, Laura Rodriguez, Fang, Guocheng, Grimes, Susan M., Lu, Hongxu, Huang, Robert J., Boyle, Sarah T., Venhuizen, Jeron, Castillo, Lesley, Tavakoli, Javad, Skhinas, Joanna N., Millar, Ewan K. A., Beretov, Julia, Rossello, Fernando J., Tipper, Joanne L., Ormandy, Christopher J., Samuel, Michael S., Cox, Thomas R., Martelotto, Luciano, Jin, Dayong, Valdes‐Mora, Fatima, Ji, Hanlee P., Gallego‐Ortega, David
Publicado 2022

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

por Jackson, Evangeline R., Duchatel, Ryan J., Staudt, Dilana E., Persson, Mika L., Mannan, Abdul, Yadavilli, Sridevi, Parackal, Sarah, Game, Shaye, Chong, Wai Chin, Jayasekara, W. Samantha N., Grand, Marion Le, Kearney, Padraic S., Douglas, Alicia M., Findlay, Izac J., Germon, Zacary P., McEwen, Holly P., Beitaki, Tyrone S., Patabendige, Adjanie, Skerrett-Byrne, David A., Nixon, Brett, Smith, Nathan D., Day, Bryan, Manoharan, Neevika, Nagabushan, Sumanth, Hansford, Jordan R., Govender, Dinisha, McCowage, Geoff B., Firestein, Ron, Howlett, Meegan, Endersby, Raelene, Gottardo, Nicholas G., Alvaro, Frank, Waszak, Sebastian M., Larsen, Martin R., Colino-Sanguino, Yolanda, Valdes-Mora, Fatima, Rakotomalala, Andria, Meignan, Samuel, Pasquier, Eddy, André, Nicolas, Hulleman, Esther, Eisenstat, David D., Vitanza, Nicholas A., Nazarian, Javad, Koschmann, Carl, Mueller, Sabine, Cain, Jason E., Dun, Matthew D.
Publicado 2023